Clear information. Your next step.How we’re funded

Your first online NAD+ visit: a checklist to keep beside you

Prepare your questions, medication list, budget, and follow-up expectations.

An online intake can be convenient, but a short form should lead to a real clinical decision. You deserve to understand why treatment is being considered, what remains uncertain, and what happens after the first shipment.

Before starting, gather a current medication list and write down the concern you want help with. A specific description of the problem is more useful than simply asking whether you qualify for NAD+.

The useful takeaway

A good visit ends with a clear decision, understandable instructions, and a follow-up plan.

Describe the change that brought you here

Note when symptoms began, whether they are getting worse, what activities they affect, and what you have already tried. Include recent changes in sleep, illnesses, medicines, or supplements. Do not assume that age or low NAD+ explains the problem.

Tell the clinician about your medical history and any prior reactions. If the concern needs in-person assessment or additional testing, the next step may be a referral rather than a prescription. Our guide for adults over 50 discusses that starting point.

Ask about the evidence in plain language

Ask what benefit is reasonably being considered and which studies support it for this formulation and route. A helpful explanation should distinguish biological plausibility from demonstrated improvement in people.

Ask what alternatives deserve consideration, including addressing the underlying symptom through your regular clinician. Read the evidence guide beforehand so that unfamiliar terminology does not dominate the conversation.

Make the prescription understandable

If treatment is prescribed, confirm the exact product, route, directions, and pharmacy. Ask for instruction that accounts for your vision, dexterity, comfort, and ability to store the medication. A caregiver may be able to participate with your permission.

Do not guess when the written label and verbal explanation differ. The label guide identifies the details to clarify. You should know how to reach the prescriber and pharmacist before administering anything.

Set the financial boundaries

Ask for the complete initial payment, recurring charges, supply duration, and cancellation rules. Specify whether you are willing to make a multi-month commitment. If treatment is declined, find out which charges are refunded and which are not.

Use our pricing guide to compare the answer with other providers. A promotion should not pressure you to skip questions about either medical suitability or cost.

Agree on follow-up before you start

Choose a meaningful goal with the clinician and agree on a review date. Ask what would support continuing, changing, or stopping. Record unwanted effects as carefully as hoped-for improvements.

Know the difference between routine messaging and urgent care. The safety guide explains why severe symptoms should not wait for a portal reply. Keep the clinic and pharmacy contact details somewhere easy to find.

A short list to bring with you

You can print this page from your browser or save it as a PDF. Leave room beside each item for the answer.

  • What else could explain the symptom I want to improve?
  • What evidence applies to this exact treatment?
  • Who is my clinician and which pharmacy will dispense it?
  • What will I pay today and at renewal?
  • How will I learn to use and store the product?
  • When do we reassess, and whom do I contact if I feel unwell?

Follow the source

References & further reading

  1. HHS — licensing across state lines

    Licensing pathways vary by state and profession; confirm your clinician can treat you where you are located.

  2. FSMB — state medical board directory

    Find the appropriate state regulator and license lookup.

  3. NABP — boards of pharmacy

    Find the pharmacy regulator for your state.

  4. FDA — ingredients suitable for sterile compounding

    Reports NAD+ injectable adverse events and ingredient-quality concerns.

  5. Grant et al. (2019) — human NAD+ infusion pilot

    Small IV metabolism study; does not establish benefits of home injections.

Source review: September 19, 2026. Published pages are educational; they have not been independently medically reviewed.